Dem Ilhan Omar Demands Evidence of Criminal Illegal Alien Arrests in MN Days...
Tragic Spell: Chicago Teachers Union Deletes Post Asking ‘Governer’ JB Pritzker to Tax...
'Abolish ICE' on Ice? Political Group Advises Dem Party to Pretend NOT to...
Liberal Influencer Says She’s at the Firing Range Training to Kill ‘MAGA F**ks’
ICE Allegedly Shut Down the Oldest Mexican Restaurant in Aaron Rupar’s Hometown
Bernie Sanders Introduces Bill Banning Presidents From Naming Buildings After Themselves
Media Spins Mass Exodus Over ICE Shooting—Shipwreckedcrew Drops the Truth: It's All About...
NYT: MN Prosecutors Resign After Push to Investigate Renee Good’s Wife
From 'Elephants Are Not Birds' to 'Principles Are Not Permanent': Ashley St. Clair's...
From 'I'm Not a Biologist' to 'CisGINGER' Queen: KBJ Just Gave Redheads the...
Vigil Held for Father of Two Killed by Off-Duty ICE Agent
Don Lemon Asks If This Is What You Voted For, MAGA, You 'F**king...
Lee Zeldin Calls Out the Gaslighting New York Times For Fake Story About...
Leftist PA Brags About $200K and Degree — ICE Hero Responds: High School...
Crying Woman Shaves Her Head to Protest Shooting of 'Renee Cook'

Christina Pushaw busts the AP for acknowledging a COVID treatment fact they shamed Ron DeSantis for pointing out just a few months ago

Yesterday, the Associated Press’ Matthew Perrone reported a possible setback for a couple of COVID19 treatments, including Regeneron.

Advertisement

More from the AP:

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which contains dozens of mutations that make it harder for antibodies to attack the virus. And while the companies say they can quickly develop new omicron-targeting antibodies, those aren’t expected to launch for at least several months.

The fact that Regeneron may not be as effective against the omicron variant as it’s been against others is noteworthy enough. But Gov. Ron DeSantis’ press secretary Christina Pushaw finds something else noteworthy, too:

Things sure have changed, haven’t they? Recall this past August, when the AP was entertaining the idea that DeSantis was promoting sketchy Regeneron in some kind of quid pro quo scheme because one of his top donors had invested money in Regeneron, making DeSantis shady AF and not to be trusted.

Advertisement

Pushaw called out the AP then.

Just like she’s calling out the AP now.

We’ve got whiplash.

And Pushaw’s got one last question for the AP:

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos

Advertisement
Advertisement
Advertisement